View in EDS

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.

Saved in:
Bibliographic Details
Title: Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
Authors: Woodhouse LJ; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK., Appleton JP; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Ankolekar S; Department of Neurology, King's College Hospital NHS Trust, London, UK., England TJ; Vascular Medicine, Division of Medical Sciences and GEM, Royal Derby Hospital, Derby, UK., Mair G; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK., Muir K; Neurology, University of Glasgow, Glasgow, UK., Price CI; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK., Pocock S; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Randall M; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Robinson TG; Department of Cardiovascular Sciences, and NIHR Biomedical Research Unit for Cardiovascular Diseases, University of Leicester, Leicester, UK., Roffe C; Institute for Science and Technology in Medicine, Keele University, Keele, UK., Sandset EC; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Research and Development, Norwegian Air Ambulance Foundation, Oslo, Norway., Saver JL; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, Los Angeles, California, USA., Siriwardena AN; Community and Health Research Unit, University of Lincoln, Lincoln, UK., Sprigg N; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK., Wardlaw JM; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK., Bath PM; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Corporate Authors: RIGHT-2 Investigators
Source: BMJ neurology open [BMJ Neurol Open] 2023 Jun 27; Vol. 5 (1), pp. e000424. Date of Electronic Publication: 2023 Jun 27 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: British Medical Association Country of Publication: England NLM ID: 101775450 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-6140 (Electronic) Linking ISSN: 26326140 NLM ISO Abbreviation: BMJ Neurol Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37564156
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Woodhouse+LJ%22">Woodhouse LJ</searchLink>; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Appleton+JP%22">Appleton JP</searchLink>; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Ankolekar+S%22">Ankolekar S</searchLink>; Department of Neurology, King's College Hospital NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22England+TJ%22">England TJ</searchLink>; Vascular Medicine, Division of Medical Sciences and GEM, Royal Derby Hospital, Derby, UK.<br /><searchLink fieldCode="AU" term="%22Mair+G%22">Mair G</searchLink>; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Muir+K%22">Muir K</searchLink>; Neurology, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Price+CI%22">Price CI</searchLink>; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Pocock+S%22">Pocock S</searchLink>; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Randall+M%22">Randall M</searchLink>; Department of Neurology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Robinson+TG%22">Robinson TG</searchLink>; Department of Cardiovascular Sciences, and NIHR Biomedical Research Unit for Cardiovascular Diseases, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Roffe+C%22">Roffe C</searchLink>; Institute for Science and Technology in Medicine, Keele University, Keele, UK.<br /><searchLink fieldCode="AU" term="%22Sandset+EC%22">Sandset EC</searchLink>; Department of Neurology, Oslo University Hospital, Oslo, Norway.; Research and Development, Norwegian Air Ambulance Foundation, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Saver+JL%22">Saver JL</searchLink>; Department of Neurology and Comprehensive Stroke Center, David Geffen School of Medicine, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Siriwardena+AN%22">Siriwardena AN</searchLink>; Community and Health Research Unit, University of Lincoln, Lincoln, UK.<br /><searchLink fieldCode="AU" term="%22Sprigg+N%22">Sprigg N</searchLink>; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Wardlaw+JM%22">Wardlaw JM</searchLink>; UK Dementia Research Institute, The University of Edinburgh Centre for Clinical Brain Sciences, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Bath+PM%22">Bath PM</searchLink>; Stroke Trials Unit, Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.; Stroke, Nottingham University Hospitals NHS Trust, Nottingham, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RIGHT-2+Investigators%22">RIGHT-2 Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101775450%22">BMJ neurology open</searchLink> [BMJ Neurol Open] 2023 Jun 27; Vol. 5 (1), pp. e000424. <i>Date of Electronic Publication: </i>2023 Jun 27 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Association%22">British Medical Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101775450 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-6140 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226326140%22">26326140 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Neurol Open <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37564156
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/bmjno-2023-000424
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e000424
    Titles:
      – TitleFull: Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Woodhouse LJ
      – PersonEntity:
          Name:
            NameFull: Appleton JP
      – PersonEntity:
          Name:
            NameFull: Ankolekar S
      – PersonEntity:
          Name:
            NameFull: England TJ
      – PersonEntity:
          Name:
            NameFull: Mair G
      – PersonEntity:
          Name:
            NameFull: Muir K
      – PersonEntity:
          Name:
            NameFull: Price CI
      – PersonEntity:
          Name:
            NameFull: Pocock S
      – PersonEntity:
          Name:
            NameFull: Randall M
      – PersonEntity:
          Name:
            NameFull: Robinson TG
      – PersonEntity:
          Name:
            NameFull: Roffe C
      – PersonEntity:
          Name:
            NameFull: Sandset EC
      – PersonEntity:
          Name:
            NameFull: Saver JL
      – PersonEntity:
          Name:
            NameFull: Siriwardena AN
      – PersonEntity:
          Name:
            NameFull: Sprigg N
      – PersonEntity:
          Name:
            NameFull: Wardlaw JM
      – PersonEntity:
          Name:
            NameFull: Bath PM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 06
              Text: 2023 Jun 27
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2632-6140
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMJ neurology open
              Type: main
ResultId 1